Oncology Pipeline Database 2017: Indication, Clinical Trial Stages, Drug Mechanism Classes & Company - Research and Markets

DUBLIN, Jan. 24, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Oncology Pipeline Database - 2017" drug pipelines to their offering.

Oncology Pipeline Highlights Database - 2017, provides most up-to-date information on key pipeline products in the global Oncology Drug market. It covers emerging therapies for Oncology indications in active clinical development stages including early and late stage clinical trials.

Key indications covered in this database include Esophageal Cancer Stomach Cancer, Colon Cancer, Pancreatic Cancer, Malignant Melanoma, Breast Cancer, Cervical Cancer, Ovary Cancer, Prostate Cancer, Renal Cancer, Bladder Cancer, Brain Cancer, Hodgkin's disease, Acute Myeloid Leukemia and Multiple Myeloma. The pipeline data is presented in an excel dashboard with filtering options.

The pipeline data presented in this database helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

By Indication:
The database presents pipeline by Oncology indications. Key indications covered in this database include Esophageal Cancer Stomach Cancer, Colon Cancer, Pancreatic Cancer, Malignant Melanoma, Breast Cancer, Cervical Cancer, Ovary Cancer, Prostate Cancer, Renal Cancer, Bladder Cancer, Brain Cancer, Hodgkin's disease, Acute Myeloid Leukemia and Multiple Myeloma.

By Clinical Trial Stages:
The database provides Oncology pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

By Drug Mechanism Classes:
The database provides Oncology pipeline products by their dominant drug mechanism class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

By Company:
The database provides Oncology pipeline products by the company.

Summary:
- Oncology Pipeline by Indication
- Oncology Pipeline by Clinical Trial Phase
- Oncology Pipeline by Drug Mechanism Classes
- Oncology Pipeline by Company

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/c58v6w/oncology_pipeline

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/oncology-pipeline-database-2017-indication-clinical-trial-stages-drug-mechanism-classes--company---research-and-markets-300395617.html

SOURCE Research and Markets